In this episode of Susan G. Komen’s Breast Cancer Breakthroughs series, Susan G. Komen’s Senior Vice President of Mission Victoria Smart joins Dr. Antonio Wolff, a medical oncologist at Johns Hopkins University, and Dr. Daniel Stover, a medical oncologist at The James Cancer Center at the Ohio State University, to discuss new possibilities for breast cancer patients through treatment de-escalation.

As researchers continue to seek promising new breast cancer treatments for patients, they are now shifting their focus from a standardized, “one-size-fits-all” approach to a more individualized practice known as precision medicine.

Komen Scholar Angela DeMichele, M.D., MSCE, has a vision to find the cures for metastatic breast cancer (MBC). As a professor of medicine at the University of Pennsylvania, Dr. DeMichele’s research focuses on new therapies for breast cancer and preventing breast cancer recurrence.

Inflammatory breast cancer (IBC) is an aggressive breast cancer that develops rapidly and often does not present as a lump, making it harder to spot on a mammogram. Instead, people notice symptoms such as a rash or swelling, which can easily be confused with a breast infection. IBC can progress rapidly and is often at […]

Susan G. Komen launched the first episode of an exciting new educational series called Breast Cancer Breakthroughs where industry experts, scientists and patient advocates share and discuss the newest developments in breast cancer research and technology on the horizon for patients.

Dr. Anne Marie McCarthy, Ph.D., is focused on developing new ways to identify women who are at a high risk for aggressive breast cancer, especially individuals from historically marginalized populations.

Ann H. Partridge, M.D., MPH, and Jennifer Pietenpol, Ph.D., are making history at Susan G. Komen. For the first time, two women are serving simultaneously as the Chief Scientific Advisors, guiding Komen’s research strategy, investments and programs.

When Ashley Fernandez felt a lump and asked her doctor for an ultrasound, she was told that at 31 years old and with no family history of breast cancer, she was too young to have the disease. As a mother of a 3-year-old balancing her Air Force family’s busy life, Ashley tried to put the lump out of her mind. But a month later, it was still there.

For Geoffrey M. Wahl, Ph.D., a former Komen scholar, helping others who face serious diseases has been a passion ever since he battled an aggressive viral encephalitis as a child.

Norman Wolmark, M.D., FACS, FRCSC, is renowned for pioneering lumpectomy as the standard of care for invasive and non-invasive breast cancer. His groundbreaking work to eliminate the need for radical mastectomy has improved the quality of life for countless breast cancer patients worldwide.

Susan G. Komen® hosted the Metastatic Breast Cancer (MBC) Collaborative Research Summit on October 13, 2022, in Durham, North Carolina.

Komen Scholar Dr. Yibin Kang’s work revolves around metastatic breast cancer, with his research focused on blocking a protein that allows breast cancers to spread to the bone. Learn why Dr. Kang is passionate about finding cures.